Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Drug Combination Signatures for Prediction and Mitigation of Toxicity [single cell]

ABSTRACT: Drug Combination Signatures for Prediction and Mitigation of Toxicity [single cell]

PROVIDER: PRJNA733493 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR14678517.fastq.gz	Fastqsanger.gz
	SRR14678518.fastq.gz	Fastqsanger.gz
	SRR14678519.fastq.gz	Fastqsanger.gz
	SRR14678520.fastq.gz	Fastqsanger.gz
	SRR14678521.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

Drug Combination Signatures for Prediction and Mitigation of Toxicity.

Project description:Drug Combination Signatures for Prediction and Mitigation of Toxicity.

| PRJNA731502 | ENA

Drug Combination Signatures for Prediction and Mitigation of Toxicity

Project description:Drug Combination Signatures for Prediction and Mitigation of Toxicity

| PRJNA657744 | ENA

Drug Combination Signatures for Prediction and Mitigation of Toxicity

Project description:Generation and extensive characterization of a gender-balanced, racially/ethnically diverse library of iPSCs from forty clinically healthy human individuals who range in age from 22-61. Specifically, here we provide mRNAseq data of duplicate samples of one clone from each of these forty iPSC lines.

2020-11-30 | GSE156384 | GEO

Drug Combination Signatures for Prediction and Mitigation of Toxicity.

Project description:Baseline transcriptomic signatures of cardiomyocytes differentiated from hiPSC lines generated from clinically well-characterized, diverse healthy human individuals. We provide mRNAseq data of various replicate samples of cardiomyocytes differentiated from 6 hiPSC lines.

2021-05-21 | GSE174773 | GEO

Drug Combination Signatures for Prediction and Mitigation of Toxicity [single cell]

Project description:Single cell transcriptomic signatures of cardiomyocytes differentiated from hiPSC lines generated from clinically well-characterized, diverse healthy human individuals. We provide single cell mRNAseq data of cardiomyocytes differentiated from 4 hiPSC lines.

2021-05-29 | GSE175761 | GEO

The differentiation state of small intestinal organoid models influences prediction of drug-induced toxicity

Project description:The differentiation state of small intestinal organoid models influences prediction of drug-induced toxicity

| PRJNA1162903 | ENA

Proteomic cellular signatures of kinase inhibitor-induced cardiotoxicity

Project description:Drug Toxicity Signature Generation Center (DToxS) at the Icahn School of Medicine at Mount Sinai is an integral part of the NIH Library of Integrated Network-Based Cellular Signatures (LINCS) program. A key aim of DToxS is to generate both proteomic and transcriptomic signatures that cab predict adverse effects, especially cardiotoxicity, of drugs approved by the Food and Drug Administration. Towards this goal, high throughput shot-gun proteomics experiments (308 cell line/drug combinations + 64 HeLa control lysates + 9 auxiliary treatment samples) have been conducted at the Center for Advanced Proteomics Research at Rutgers-New Jersey Medical School. The integrated proteomic and transcriptomic signatures have been used for computational network analysis to identify cellular signatures of cardiotoxicity that may predict drug-induced toxicity and possible mitigation of such toxicities by mixing different drugs. Both raw and processed proteomics data have been carefully controlled for quality and have been made publicly available via the PRoteomics IDEntifications (PRIDE) database. As such, this broad drug-stimulated proteomic dataset is valuable for the prediction drug toxicities and their mitigation.

2021-10-18 | PXD014791 | Pride

The differentiation state of small intestinal organoid models influences prediction of drug-induced toxicity

Project description:Drug-induced intestinal toxicity (GIT) is a frequent dose-limiting adverse event that can impact patient compliance and treatment outcomes. In vivo, there are proliferative and differentiated cell types critical to maintaining intestinal homeostasis. Traditional in vitro models using transformed cell lines do not capture this cellular complexity, and often fail to predict intestinal toxicity. Primary tissue-derived intestinal organoids, on the other hand, are a scalable Complex in vitro Model (CIVM) that recapitulates major intestinal cell lineages and function. Intestinal organoid toxicity assays have been shown to correlate with clinical incidence of drug-induced diarrhea, however existing studies do not consider how differentiation state of the organoids impact assay readouts and predictivity. We employed distinct proliferative and differentiated organoid models of the small intestine to assess whether differentiation state alone can alter toxicity responses to small molecule compounds in cell viability assays. In doing so, we identified several examples of small molecules which elicit differential toxicity in proliferative and differentiated organoid models. This proof of concept highlights the need to consider which cell types are present in CIVMs, their differentiation state, and how this alters interpretation of toxicity assays.

2025-01-23 | GSE277613 | GEO

Testicular toxicity induced by carbendazim, iprodione, alone or in combination

Project description:Using an ex-vivo testicular culture from rats, we carried out transcriptomic experiments to identify the pathway of toxicity ellicited by the fungicides carbendazim, iprodione alone or in combination. we used commercial Agilent Microarray GE 4x44K Rat (V3) Gene Expression Microarray (G2514F) AMADID : 028282

2016-07-01 | GSE75446 | GEO

Drug combination sci-Plex Data

Project description:Drug combination sci-Plex Data

| PRJNA851906 | ENA